Document is current
Any future updates will be listed below
-
Authors
Zanuttini, Luca
Colombo, Elisa
Menna, Grazia
Staartjes, Victor E.
van Doormaal, Tristan
Krayenbühl, Niklaus
Regli, Luca
Serra, Carlo
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 13 July 2025
Accepted: 18 August 2025
First Online: 2 September 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by Kantonale Ethikkommission Zürich (KEK-ZH-PB-2017–00093).
: Informed consent was obtained from all individual participants included in the study.
: Dr. T. van Doormaal is the founder and Chief Medical Officer of Augmedit BV, an Augmedit reality company.
